HEADER TRANSFERASE 20-DEC-07 3BQC TITLE HIGH PH-VALUE CRYSTAL STRUCTURE OF EMODIN IN COMPLEX WITH TITLE 2 THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASEIN KINASE II SUBUNIT ALPHA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 1-335; COMPND 5 SYNONYM: CASEIN KINASE II, ALPHA CHAIN, CK II; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSNK2A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PT7-7 KEYWDS PROTEIN KINASE CK2, CASEIN KINASE 2, EUKARYOTIC PROTEIN KEYWDS 2 KINASES, EMODIN, ATP-COMPETITIVE INHIBITOR, ATP-BINDING, KEYWDS 3 NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN KINASE, KEYWDS 4 TRANSFERASE, WNT SIGNALING PATHWAY EXPDTA X-RAY DIFFRACTION AUTHOR K.NIEFIND,J.RAAF,O.-G.ISSINGER REVDAT 3 24-FEB-09 3BQC 1 VERSN REVDAT 2 18-MAR-08 3BQC 1 JRNL REVDAT 1 15-JAN-08 3BQC 0 JRNL AUTH J.RAAF,K.KLOPFFLEISCH,O.-G.ISSINGER,K.NIEFIND JRNL TITL THE CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2 JRNL TITL 2 STRUCTURALLY DEVIATES FROM ITS MAIZE HOMOLOGUE IN JRNL TITL 3 COMPLEX WITH THE NUCLEOTIDE COMPETITIVE INHIBITOR JRNL TITL 4 EMODIN JRNL REF J.MOL.BIOL. V. 377 1 2008 JRNL REFN ISSN 0022-2836 JRNL PMID 18242640 JRNL DOI 10.1016/J.JMB.2008.01.008 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.26 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 47602 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.133 REMARK 3 R VALUE (WORKING SET) : 0.130 REMARK 3 FREE R VALUE : 0.197 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2557 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.54 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3360 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.56 REMARK 3 BIN R VALUE (WORKING SET) : 0.1560 REMARK 3 BIN FREE R VALUE SET COUNT : 192 REMARK 3 BIN FREE R VALUE : 0.2600 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2828 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 22 REMARK 3 SOLVENT ATOMS : 300 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.93 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.61000 REMARK 3 B22 (A**2) : 0.87000 REMARK 3 B33 (A**2) : -0.02000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.32000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.080 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.078 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.054 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.221 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.980 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.958 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2933 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2033 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3984 ; 1.390 ; 1.955 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4902 ; 0.930 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 341 ; 5.681 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 158 ;32.663 ;23.101 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 514 ;13.113 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;21.333 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 409 ; 0.089 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3273 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 644 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 623 ; 0.223 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2214 ; 0.199 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1453 ; 0.185 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1485 ; 0.085 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 228 ; 0.164 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 18 ; 0.132 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 73 ; 0.321 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 21 ; 0.173 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2190 ; 4.889 ; 6.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 668 ; 2.283 ; 6.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2747 ; 5.558 ; 9.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1582 ; 5.740 ; 6.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1237 ; 7.173 ; 9.000 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 3 A 10 REMARK 3 RESIDUE RANGE : A 117 A 330 REMARK 3 ORIGIN FOR THE GROUP (A): -3.4790 -58.6640 -42.0290 REMARK 3 T TENSOR REMARK 3 T11: -0.0424 T22: -0.0969 REMARK 3 T33: -0.0830 T12: 0.0012 REMARK 3 T13: -0.0148 T23: -0.0147 REMARK 3 L TENSOR REMARK 3 L11: 1.1396 L22: 1.0075 REMARK 3 L33: 1.1315 L12: -0.0451 REMARK 3 L13: -0.0878 L23: -0.0440 REMARK 3 S TENSOR REMARK 3 S11: -0.0029 S12: 0.0817 S13: -0.0154 REMARK 3 S21: 0.1334 S22: 0.0384 S23: -0.0590 REMARK 3 S31: -0.0513 S32: 0.0122 S33: -0.0354 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 11 A 116 REMARK 3 ORIGIN FOR THE GROUP (A): 21.5120 -63.2740 -46.4970 REMARK 3 T TENSOR REMARK 3 T11: -0.0245 T22: 0.0686 REMARK 3 T33: 0.0992 T12: 0.0464 REMARK 3 T13: -0.0205 T23: -0.0920 REMARK 3 L TENSOR REMARK 3 L11: 4.9085 L22: 1.2345 REMARK 3 L33: 1.5308 L12: 2.4365 REMARK 3 L13: 0.7303 L23: 0.1832 REMARK 3 S TENSOR REMARK 3 S11: 0.0323 S12: 0.1281 S13: -0.4884 REMARK 3 S21: 0.1374 S22: 0.0187 S23: -0.3061 REMARK 3 S31: 0.0432 S32: 0.2978 S33: -0.0510 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS REMARK 4 REMARK 4 3BQC COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 25-DEC-07. REMARK 100 THE RCSB ID CODE IS RCSB045835. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-FEB-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : BW7B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.84 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 50159 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 34.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.03600 REMARK 200 R SYM (I) : 0.03600 REMARK 200 FOR THE DATA SET : 35.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : 0.60700 REMARK 200 R SYM FOR SHELL (I) : 0.60700 REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 1PJK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN STOCK SOLUTION: 10MG/ML REMARK 280 PROTEIN IN 500MM NACL, 25MM TRIS/HCL, PH 8.5 EMODIN STOCK REMARK 280 SOLUTION: 10MM IN WATER PROTEIN/EMODIN MIXTURE: EQUAL VOLUMES REMARK 280 OF PROTEIN AND EMODIN STOCK SOLUTIONS WERE MIXED AND REMARK 280 EQUILLIBRATED FOR 30 MIN PRIOR TO CRYSTALLIZATION RESERVOIR: REMARK 280 30% PEG4000, 0.2M LITHIUM SULFATE, 0.1M TRIS/HCL, PH 8.5 REMARK 280 CRYSTALLIZATION DROP: 2 MIKROLITERS PROTEIN/EMODIN MIXTURE REMARK 280 PLUS 1 MIKROLITER RESERVOIR SOLUTION, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 22.87000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLN A 331 REMARK 465 ALA A 332 REMARK 465 ARG A 333 REMARK 465 MET A 334 REMARK 465 GLY A 335 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 507 O HOH A 677 2.00 REMARK 500 O HOH A 412 O HOH A 693 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 80 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG A 80 NE - CZ - NH2 ANGL. DEV. = -3.9 DEGREES REMARK 500 ARG A 316 NE - CZ - NH2 ANGL. DEV. = 3.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 73 -74.51 -137.68 REMARK 500 LYS A 74 116.16 -163.43 REMARK 500 ASP A 156 43.22 -149.10 REMARK 500 ASP A 175 76.18 51.27 REMARK 500 ALA A 193 162.04 60.96 REMARK 500 ASP A 205 31.30 70.80 REMARK 500 MET A 208 55.42 -94.36 REMARK 500 HIS A 234 68.99 -105.26 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 699 DISTANCE = 5.15 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 336 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 337 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EMO A 400 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2PVR RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN COMPLEX WITH ADENYLYL IMIDODIPHOSPHATE REMARK 900 (AMPPNP) AND SULFATE REMARK 900 RELATED ID: 2RKP RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN COMPLEX WITH 5,6-DICHLORO BENZIMIDAZOLE REMARK 900 -BETA-D- RIBOFURANOSIDE REMARK 900 RELATED ID: 1F0Q RELATED DB: PDB REMARK 900 THE SAME INHIBITOR (EMODIN) WITH THE HOMOLOGOUS ENYZME FROM REMARK 900 ZEA MAYS REMARK 900 RELATED ID: 1JWH RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN COMPLEX WITH A NON-CATALYTIC SUBUNIT DBREF 3BQC A 1 335 UNP P68400 CSK21_HUMAN 1 335 SEQRES 1 A 335 MET SER GLY PRO VAL PRO SER ARG ALA ARG VAL TYR THR SEQRES 2 A 335 ASP VAL ASN THR HIS ARG PRO ARG GLU TYR TRP ASP TYR SEQRES 3 A 335 GLU SER HIS VAL VAL GLU TRP GLY ASN GLN ASP ASP TYR SEQRES 4 A 335 GLN LEU VAL ARG LYS LEU GLY ARG GLY LYS TYR SER GLU SEQRES 5 A 335 VAL PHE GLU ALA ILE ASN ILE THR ASN ASN GLU LYS VAL SEQRES 6 A 335 VAL VAL LYS ILE LEU LYS PRO VAL LYS LYS LYS LYS ILE SEQRES 7 A 335 LYS ARG GLU ILE LYS ILE LEU GLU ASN LEU ARG GLY GLY SEQRES 8 A 335 PRO ASN ILE ILE THR LEU ALA ASP ILE VAL LYS ASP PRO SEQRES 9 A 335 VAL SER ARG THR PRO ALA LEU VAL PHE GLU HIS VAL ASN SEQRES 10 A 335 ASN THR ASP PHE LYS GLN LEU TYR GLN THR LEU THR ASP SEQRES 11 A 335 TYR ASP ILE ARG PHE TYR MET TYR GLU ILE LEU LYS ALA SEQRES 12 A 335 LEU ASP TYR CYS HIS SER MET GLY ILE MET HIS ARG ASP SEQRES 13 A 335 VAL LYS PRO HIS ASN VAL MET ILE ASP HIS GLU HIS ARG SEQRES 14 A 335 LYS LEU ARG LEU ILE ASP TRP GLY LEU ALA GLU PHE TYR SEQRES 15 A 335 HIS PRO GLY GLN GLU TYR ASN VAL ARG VAL ALA SER ARG SEQRES 16 A 335 TYR PHE LYS GLY PRO GLU LEU LEU VAL ASP TYR GLN MET SEQRES 17 A 335 TYR ASP TYR SER LEU ASP MET TRP SER LEU GLY CYS MET SEQRES 18 A 335 LEU ALA SER MET ILE PHE ARG LYS GLU PRO PHE PHE HIS SEQRES 19 A 335 GLY HIS ASP ASN TYR ASP GLN LEU VAL ARG ILE ALA LYS SEQRES 20 A 335 VAL LEU GLY THR GLU ASP LEU TYR ASP TYR ILE ASP LYS SEQRES 21 A 335 TYR ASN ILE GLU LEU ASP PRO ARG PHE ASN ASP ILE LEU SEQRES 22 A 335 GLY ARG HIS SER ARG LYS ARG TRP GLU ARG PHE VAL HIS SEQRES 23 A 335 SER GLU ASN GLN HIS LEU VAL SER PRO GLU ALA LEU ASP SEQRES 24 A 335 PHE LEU ASP LYS LEU LEU ARG TYR ASP HIS GLN SER ARG SEQRES 25 A 335 LEU THR ALA ARG GLU ALA MET GLU HIS PRO TYR PHE TYR SEQRES 26 A 335 THR VAL VAL LYS ASP GLN ALA ARG MET GLY HET CL A 336 1 HET CL A 337 1 HET EMO A 400 20 HETNAM CL CHLORIDE ION HETNAM EMO 3-METHYL-1,6,8-TRIHYDROXYANTHRAQUINONE HETSYN EMO EMODIN FORMUL 2 CL 2(CL 1-) FORMUL 4 EMO C15 H10 O5 FORMUL 5 HOH *300(H2 O) HELIX 1 1 PRO A 20 ASP A 25 1 6 HELIX 2 2 TYR A 26 HIS A 29 5 4 HELIX 3 3 ASN A 35 ASP A 37 5 3 HELIX 4 4 LYS A 74 ARG A 89 1 16 HELIX 5 5 ASP A 120 LEU A 124 5 5 HELIX 6 6 THR A 129 MET A 150 1 22 HELIX 7 7 LYS A 158 HIS A 160 5 3 HELIX 8 8 ASP A 175 ALA A 179 5 5 HELIX 9 9 SER A 194 LYS A 198 5 5 HELIX 10 10 GLY A 199 VAL A 204 1 6 HELIX 11 11 TYR A 211 ARG A 228 1 18 HELIX 12 12 ASP A 237 GLY A 250 1 14 HELIX 13 13 GLY A 250 TYR A 261 1 12 HELIX 14 14 ASP A 266 ILE A 272 5 7 HELIX 15 15 ARG A 280 VAL A 285 5 6 HELIX 16 16 ASN A 289 VAL A 293 5 5 HELIX 17 17 SER A 294 LEU A 305 1 12 HELIX 18 18 ASP A 308 ARG A 312 5 5 HELIX 19 19 THR A 314 GLU A 320 1 7 HELIX 20 20 HIS A 321 TYR A 325 5 5 SHEET 1 A 5 TYR A 39 ARG A 47 0 SHEET 2 A 5 SER A 51 ASN A 58 -1 O GLU A 55 N VAL A 42 SHEET 3 A 5 LYS A 64 LEU A 70 -1 O VAL A 67 N PHE A 54 SHEET 4 A 5 PRO A 109 GLU A 114 -1 O PHE A 113 N VAL A 66 SHEET 5 A 5 LEU A 97 LYS A 102 -1 N VAL A 101 O ALA A 110 SHEET 1 B 2 ILE A 152 MET A 153 0 SHEET 2 B 2 GLU A 180 PHE A 181 -1 O GLU A 180 N MET A 153 SHEET 1 C 2 VAL A 162 ASP A 165 0 SHEET 2 C 2 LYS A 170 LEU A 173 -1 O LYS A 170 N ASP A 165 CISPEP 1 GLU A 230 PRO A 231 0 -9.15 SITE 1 AC1 2 ARG A 80 ARG A 155 SITE 1 AC2 5 HIS A 148 THR A 314 ALA A 315 HOH A 431 SITE 2 AC2 5 HOH A 462 SITE 1 AC3 12 VAL A 53 VAL A 66 LYS A 68 ILE A 95 SITE 2 AC3 12 PHE A 113 VAL A 116 ASN A 118 MET A 163 SITE 3 AC3 12 ILE A 174 ASP A 175 HOH A 405 HOH A 432 CRYST1 58.870 45.740 63.500 90.00 111.78 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016987 0.000000 0.006787 0.00000 SCALE2 0.000000 0.021863 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016959 0.00000